ScienceDirect significantly improves access to Elsevier content
Introduction of Accepted Manuscripts and other enhancements improve availability of research results
Amsterdam, 20 January 2006 – Access to Elsevier’s full-text, peer-reviewed journal and book content on its premier web platform, ScienceDirect, will be significantly enhanced with several new features.
As part of Elsevier’s commitment to provide the latest scientific research as soon as possible online, ScienceDirect will introduce a new type of Article in Press in February, 2006: Accepted Manuscripts. These are manuscripts which have been peer-reviewed and selected for publication by the journal editor but have yet to be edited by Elsevier’s production staff. Accepted Manuscripts will be available for around 200 journals from February 2006, with further titles to be added throughout the year. The new manuscripts will be available on average five days after acceptance; four-to-six weeks earlier than is currently the case. Additionally, the PDF articles will be citable using DOI (Digital Object Identifier) and searchable on title, author name and full text. This represents a significant step forward in reducing publication delay and promoting rapid dissemination of new research work.
ScienceDirect will also extend its various export options and enable the transfer of bibliographic data to RefWorks, the market-leading, web-based reference management tool from Cambridge Scientific Abstracts (CSA). From February 2006, users will be able to export selected data directly to RefWorks, which opens a web browser interface immediately on clicking the “Export” link. The advantage over current reference management desk-top applications is that users will be able to move seamlessly between the two web-based systems, making it much easier to update and manage their own collections of references. This new functionality extends the current partnership between Elsevier and CSA RefWorks. Full integration already exists for Scopus, Elsevier’s leading abstract and citation database.
Users can now also benefit from a new feature designed to assist users search and retrieve results from ScienceDirect. The feature is the result of a new software upgrade released by Ex Libris, which extends MetaLib’s® MetaSearch™ functionality. In addition to ScienceDirect’s own highly popular and intuitive user interface, end users can now search through MetaLib’s integrated library portal, thereby increasing their options for finding the high-value information they need via one search query, presented in a single search result list. This collaboration with Ex Libris signifies Elsevier’s continued commitment to providing widespread access to research literature, and comes in addition to federated search access to ScienceDirect and Scopus from Encompass, the federated search portal from Elsevier’s Endeavor.
“ScienceDirect is continually introducing new product features to provide the best possible web platform for accessing and managing full-text articles,” says Amanda Spiteri, Elsevier Product Marketing Director. “We are really pleased with this latest set of enhancements, in particular the ability to post articles within days of acceptance following peer review, which will support even more rapid access to key research results.”
# # #
ScienceDirect is the essential information resource for millions of researchers, scientists, engineers, professionals and students. It features more than a quarter of the world’s electronic collection of science, technology and medicine full-text, peer-reviewed articles.
More than 2,000 journals and hundreds of books from Elsevier - including prestigious titles such as The Lancet, Cell, Tetrahedron Letters, the Handbooks in Economics Series and the International Encyclopedia of the Social and Behavioral Sciences - are available on ScienceDirect.
Users can access more than seven million full-text articles from all fields of science. Most journal articles become available on ScienceDirect immediately after peer review and before the printed versions are issued. Additionally, users gain online access to features not available in print, such as cross-publisher linking via CrossRef, and multimedia features, such as video, audio and supplementary spreadsheet files.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
Ph: +31 20 485 2677